L. Potter, S. Abbey-hosch, and D. Dickey, Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions, Endocrine Reviews, vol.27, issue.1, pp.47-72, 2006.
DOI : 10.1210/er.2005-0014

C. Sengenes, M. Berlan, D. Glisezinski, I. Lafontan, M. Galitzky et al., Natriuretic peptides: a new lipolytic pathway in human adipocytes, The FASEB Journal, vol.14, issue.10, pp.1345-1351, 2000.
DOI : 10.1096/fj.14.10.1345

C. Moro, J. Galitzky, C. Sengenes, F. Crampes, M. Lafontan et al., Functional and Pharmacological Characterization of the Natriuretic Peptide-Dependent Lipolytic Pathway in Human Fat Cells, Journal of Pharmacology and Experimental Therapeutics, vol.308, issue.3, pp.984-992, 2004.
DOI : 10.1124/jpet.103.060913

C. Sengenes, V. Stich, M. Berlan, J. Hejnova, M. Lafontan et al., Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women, International Journal of Obesity, vol.26, issue.1, pp.24-32, 2002.
DOI : 10.1038/sj.ijo.0801845

J. Galitzky, C. Sengenes, C. Thalamas, M. Marques, J. Senard et al., The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men, J Lipid Res, vol.42, pp.536-544, 2001.

A. Birkenfeld, M. Boschmann, C. Moro, F. Adams, K. Heusser et al., Lipid Mobilization with Physiological Atrial Natriuretic Peptide Concentrations in Humans, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.6, pp.3622-3628, 2005.
DOI : 10.1210/jc.2004-1953

C. Moro, F. Crampes, C. Sengenes, D. Glisezinski, I. Galitzky et al., Atrial natriuretic peptide contributes to the physiological control of lipid mobilization in humans, The FASEB Journal, vol.18, pp.908-910, 2004.
DOI : 10.1096/fj.03-1086fje

T. Wang, M. Larson, D. Levy, E. Benjamin, E. Leip et al., Impact of Obesity on Plasma Natriuretic Peptide Levels, Impact of obesity on plasma natriuretic peptide levels, pp.594-600, 2004.
DOI : 10.1161/01.CIR.0000112582.16683.EA

S. Engeli and A. Sharma, The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension, Journal of Molecular Medicine, vol.79, issue.1, pp.21-29, 2001.
DOI : 10.1007/s001090000144

J. Jaubert, F. Jaubert, N. Martin, L. Washburn, B. Lee et al., Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3), Proceedings of the National Academy of Sciences, vol.91, issue.14, pp.10278-10283, 1999.
DOI : 10.1073/pnas.91.14.6564

S. Anker, P. Ponikowski, S. Varney, T. Chua, A. Clark et al., Wasting as independent risk factor for mortality in chronic heart failure, The Lancet, vol.349, issue.9058, pp.1050-1053
DOI : 10.1016/S0140-6736(96)07015-8

J. Lommi, M. Kupari, and H. Yki-jarvinen, Free Fatty Acid Kinetics and Oxidation in Congestive Heart Failure, The American Journal of Cardiology, vol.81, issue.1, pp.45-50, 1998.
DOI : 10.1016/S0002-9149(97)00804-7

S. Pilz, H. Scharnagl, B. Tiran, U. Seelhorst, B. Wellnitz et al., Free Fatty Acids Are Independently Associated with All-Cause and Cardiovascular Mortality in Subjects with Coronary Artery Disease, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.7, pp.2542-2547, 2006.
DOI : 10.1210/jc.2006-0195

J. Sackner-bernstein, M. Kowalski, M. Fox, and K. Aaronson, Short-term risk of HAL author manuscript inserm-00165273, 2005.